Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
FDA
Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug Launch
This is a major relief for the pharmaceutical industry company as it paves the way for an earlier-than-expected approval and launch of cancer drug gAbraxane.
Why This Pharma Giant's Shares Are Down Under Regulatory Pressure
Why This Pharma Firm's Shares Are Sinking After US FDA Notice
Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug Launch
Why This Pharma Giant's Shares Are Down Under Regulatory Pressure
Why This Pharma Firm's Shares Are Sinking After US FDA Notice
